During the past decade, Sungkyunkwan University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sungkyunkwan University" #1 collaborator was "Government-wide R&D Fund project for infectious disease research" with 1 trials as a collaborator, "Ministry of Food and Drug Safety, Korea" with 1 trials as a collaborator and "National Research Foundation of Korea" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sungkyunkwan University" are "Benzodiazepines Causing Adverse Effects in Therapeutic Use" (1 trials), "Congenital Anomaly" (1 trials), "Infection" (1 trials), "Pneumococcal Vaccine Adverse Reaction" (1 trials) and "Pregnancy Related" (1 trials). Many other conditions were trialed in "Sungkyunkwan University" in a lesser frequency.

Most popular intervention types in "Sungkyunkwan University" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "10 or 13-valent pneumococcal conjugate vaccine" (1 trials), "23-valent pneumococcal polysaccharide vaccine" (1 trials), "Benzodiazepine" (1 trials), "Influenza vaccine" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sungkyunkwan University" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sungkyunkwan University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sungkyunkwan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sungkyunkwan University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".